IP10, KC and M-CSF Are Remarkably Increased in the Brains from the Various Strains of Experimental Mice Infected with Different Scrapie Agents.

Cytokines Interferon gamma-induced protein 10 (IP10) Keratinocyte chemoattractant (KC) Macrophage colony stimulating factor (M-CSF) Prion

Journal

Virologica Sinica
ISSN: 1995-820X
Titre abrégé: Virol Sin
Pays: Netherlands
ID NLM: 101514185

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 17 09 2019
accepted: 27 11 2019
pubmed: 22 4 2020
medline: 28 9 2021
entrez: 22 4 2020
Statut: ppublish

Résumé

Activation of inflammatory cells and upregulations of a number of cytokines in the central nervous system (CNS) of patients with prion diseases are frequently observed. To evaluate the potential changes of some brain cytokines that were rarely addressed during prion infection, the levels of 17 different cytokines in the brain homogenates of mice infected with different scrapie mouse-adapted agents were firstly screened with Luminex assay. Significant upregulations of interferon gamma-induced protein 10 (IP10), keratinocyte chemoattractant (KC) and macrophage colony stimulating factor (M-CSF) were frequently detected in the brain lysates of many strains of scrapie infected mice. The upregulations of those three cytokines in the brains of scrapie infected mice were further validated by the individual specific ELISA and immunohistochemical assay. Increased specific mRNAs of IP10, M-CSF and KC in the brains of scrapie infected mice were also detected by the individual specific qRT-PCRs and IP10-specific digital PCR. Dynamic analyses of the brain samples collected at different time points post infection revealed the time-dependent increases of those three cytokines, particularly IP10 during the incubation period of scrapie infection. In addition, we also found that the levels of IP10 in cerebral spinal fluid (CSF) of 45 sporadic Creutzfeldt-Jakob disease (sCJD) patients were slightly but significantly higher than those of the cases who were excluded the diagnosis of prion diseases. These data give us a better understanding of inflammatory reaction during prion infection and progression of prion disease.

Identifiants

pubmed: 32314275
doi: 10.1007/s12250-020-00216-3
pii: 10.1007/s12250-020-00216-3
pmc: PMC7736440
doi:

Substances chimiques

Chemotactic Factors 0
PrPSc Proteins 0
Macrophage Colony-Stimulating Factor 81627-83-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

614-625

Références

J Virol. 1994 Apr;68(4):2383-7
pubmed: 8139024
Res Vet Sci. 1971 Mar;12(2):195-7
pubmed: 4995426
Transfusion. 2001 Dec;41(12):1509-14
pubmed: 11778065
Brain Res. 2002 Jun 14;940(1-2):49-54
pubmed: 12020874
J Neurosci. 2004 Jan 21;24(3):620-7
pubmed: 14736847
Int J Mol Med. 2016 Mar;37(3):716-26
pubmed: 26820255
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
pubmed: 9811807
Cell Death Dis. 2019 Mar 25;10(4):283
pubmed: 30911072
J Gen Virol. 2003 Sep;84(Pt 9):2605-2611
pubmed: 12917482
Trends Cell Biol. 1994 Jan;4(1):10-4
pubmed: 14731823
Geriatr Gerontol Int. 2017 May;17(5):839-846
pubmed: 27215446
Mol Neurobiol. 2016 Oct;53(8):5367-76
pubmed: 26440667
BMC Immunol. 2002 Oct 18;3:14
pubmed: 12385649
Inflammation. 2017 Feb;40(1):340-349
pubmed: 27878687
Parkinsons Dis. 2014;2014:903796
pubmed: 25386381
Lancet Neurol. 2009 Apr;8(4):382-97
pubmed: 19296921
Eur Cytokine Netw. 2000 Dec;11(4):690-8
pubmed: 11125315
J Immunol. 1999 Feb 15;162(4):2326-33
pubmed: 9973511
Cancer Treat Res. 2005;126:333-51
pubmed: 16209073
Eur J Neurol. 2007 Apr;14(4):e3-4
pubmed: 17388976
FEBS Lett. 2004 Oct 8;576(1-2):114-8
pubmed: 15474021
Autoimmun Rev. 2014 Mar;13(3):272-80
pubmed: 24189283
J Mol Neurosci. 2013 Nov;51(3):919-32
pubmed: 23526370
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11666-71
pubmed: 14504404
Blood. 2006 Jun 15;107(12):4650-7
pubmed: 16507779
Eur J Immunol. 2008 Aug;38(8):2168-79
pubmed: 18624292
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S210-2
pubmed: 22166438
Neurosci Lett. 2006 Aug 14;404(1-2):217-21
pubmed: 16787707
EMBO J. 2001 Jul 2;20(13):3351-8
pubmed: 11432823
Immunopharmacology. 2000 Aug;49(1-2):171-86
pubmed: 10904116
Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):17-27
pubmed: 10581394
FASEB J. 2009 Feb;23(2):613-22
pubmed: 18824519
Exp Ther Med. 2018 Jan;15(1):999-1004
pubmed: 29399107
J Virol. 2004 Dec;78(24):13697-707
pubmed: 15564479
J Cell Biochem. 2004 Nov 1;93(4):644-52
pubmed: 15660413
Neuropathology. 2001 Mar;21(1):19-24
pubmed: 11304038
Clin Microbiol Infect. 2019 Feb;25(2):169-177
pubmed: 30076971
Nat Rev Immunol. 2013 Dec;13(12):888-902
pubmed: 24189576
J Virol. 2009 Nov;83(21):11244-53
pubmed: 19710140
Ann Neurol. 1987 Jun;21(6):589-95
pubmed: 3300520
Am J Pathol. 2004 Aug;165(2):671-8
pubmed: 15277240
Vet Immunol Immunopathol. 2006 Feb 15;109(3-4):267-78
pubmed: 16169089
Neurobiol Dis. 2005 Nov;20(2):283-95
pubmed: 15886005

Auteurs

Jia Chen (J)

College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163000, China.
State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.

Cao Chen (C)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China. chencao@ivdc.chinacdc.cn.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, 310000, China. chencao@ivdc.chinacdc.cn.
Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430000, China. chencao@ivdc.chinacdc.cn.

Chao Hu (C)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, 310000, China.

Lian Liu (L)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.
College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, 163000, China.

Ying Xia (Y)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.
College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, 163000, China.

Lin Wang (L)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.
College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, 163000, China.

Wei Yang (W)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.
College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, 163000, China.

Hai-Yan Wu (HY)

College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163000, China.

Wei Zhou (W)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, 310000, China.

Kang Xiao (K)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, 310000, China.

Qi Shi (Q)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, 310000, China.

Yuezhang Wu (Y)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China.

Zhi-Bao Chen (ZB)

College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163000, China. chenzb@gdou.edu.cn.

Xiao-Ping Dong (XP)

State Key Laboratory of Infectious Disease Prevention and Control, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100000, China. dongxp238@sina.com.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, 310000, China. dongxp238@sina.com.
Center for Global Public Health, Chinese Center for Disease Control and Prevention, Beijing, 100000, China. dongxp238@sina.com.
Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430000, China. dongxp238@sina.com.
China Academy of Chinese Medical Sciences, Beijing, 100000, China. dongxp238@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH